$ACAD Company News This tiny mutual fund is no. 1 for

New Post Public Reply Private Reply Replies (0) Message Board

Feb 26, 2014 at 12:57 PM

$ACAD Company News

This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi

ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape 9:18 a.m. Feb. 24, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For ACADIA Pharmaceuticals (ACAD) 11:19 a.m. Feb. 21, 2014 - TheStreet.com
Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming 8:31 a.m. Feb. 11, 2014 - Seeking Alpha
Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options 12:00 p.m. Feb. 5, 2014 - TheStreet.com
Cramer's Lightning Round - Archer Daniels Midland Is Much Ado About Nothing (1/30/14) 6:22 a.m. Jan. 31, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Don't Bet on Boyd Gaming 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Social, Mobile, Cloud Are Buys 8:19 p.m. Jan. 30, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha
Healthcare Stocks To Avoid This Year 10:08 a.m. Jan. 7, 2014 - Seeking Alpha
4 Stocks That Could See Significant Gains In 2014 2:35 p.m. Jan. 6, 2014 - Seeking Alpha
Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days 11:52 a.m. Jan. 6, 2014 - Seeking Alpha
A Tiny-Stock Fund Is No. 1 for 2013 4:28 p.m. Jan. 5, 2014 - WSJ.com
Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV 5:59 p.m. Jan. 2, 2014 - Investors Business Daily
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Acadia: The Best Hope For Parkinson's Psychosis Sufferers 4:21 p.m. Dec. 27, 2013 - Seeking Alpha

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014 9:01 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 7:40 p.m. Oct. 31, 2013 - BusinessWire
Under The Radar Big Pharma Partnership Opportunity for Zalicus,Targacept and ACADIA 4:17 a.m. Oct. 31, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013 8:00 a.m. Oct. 30, 2013 - BusinessWire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 8:00 a.m. Oct. 29, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:05 a.m. Oct. 21, 2013 - PR Newswire
Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver 8:31 a.m. Oct. 16, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacob Walthour to Be Honored for Economic Leadership

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

American Savings Bank IPO Hits NYSE: $129M Raised

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Ransoms and Mega-Losses Surge in Cyber Claims Study

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Medicare Competitive Bidding May Slash Jobs, Access

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

B2B Growth Hinges on Narrative Coherence, Study Shows

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Goddess Maintenance Co. Eyes BeautyMatter Award

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

OrthoAtlanta Expands with Dr. Smith's Expertise Hire

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Koogler's Sale to ALL4: A Game-Changer for the Southeast

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...